AVAPS and oxygen treatment can be an effective therapeutic strategy for patients with obesity hypoventilation syndrome presenting with severe pulmonary hypertension and excessive daytime sleepiness.
May support AVAPS-oxygen in refractory OHS-PH; hypothesis-generating and requires prospective trials before clinical adoption.
Obesity and pulmonary hypertension (PH) are two conditions that frequently coexist in clinical practice and also the association between obesity and hypersomnolence has long been recognized. Pulmonary hypertension is more common (50% vs. 15%) and more severe in patients with OHS than in patients with OSAS. Here, we present an obese man with very severe excessive daytime sleep and very serious pulmonary hypertension, who only gave respond to AVAPS and oxygen treatment.
No takes yet. Share an insight, caveat, or question.
Neşe Dursunoğlu (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: